Unexpected changes in the oxic/anoxic interface in the Black Sea

THE Black Sea is the largest anoxic marine basin in the world today1. Below the layer of oxygenated surface water, hydrogen sulphide builds up to concentrations as high as 425 μM in the deep water down to a maximum depth of 2,200 m (ref. 2). The hydrographic regime is characterized by low-salinity surface water of river origin overlying high-salinity deep water of Mediterranean origin1,3. A steep pycnocline, centred at about 50 m is the primary physical barrier to mixing and is the origin of the stability of the anoxic (oxygen/hydrogen sulphide) interface. Here we report new observations, however, that indicate dramatic changes in the oceanographic characteristics of the anoxic interface of the Black Sea over decadal or shorter timescales. The anoxic, sulphide-containing interface has moved up in the water column since the last US cruises in 1969 and 1975. In addition, a suboxic zone overlays the sulphide-containing deep water. The expected overlap of oxygen and sulphide was not present. We believe that these observations result from horizontal mixing or flushing events that inject denser, saltier water into the relevant part of the water column. It is possible that man-made reduction in freshwater inflow into the Black Sea could cause these changes, although natural variability cannot be discounted. © 1989 Nature Publishing Group

Lateral injection of oxygen with the Bosporus plume - fingers of oxidizing potential in the Black Sea

Saline and warm Mediterranean water flowing through the Bosporus Strait maintains a permanent pycnocline with vertical separation of oxic (O(2)), suboxic (absence of O(2) and H(2)S), and anoxic (H(2)S) zones in the Black Sea. The stable suboxic zone implies restricted vertical mixing of the upper oxic and lower anoxic layers and limited vertical flux of oxygen that cannot balance the upward flux of sulfide. We report data that directly confirm massive lateral injections (>200 km from the Bosporus) of oxygen-enriched waters of the Bosporus plume, created by the mixing of shallow, cold, intermediate-layer Black Sea water with Mediterranean water. These plume waters are laterally injected into the oxic layer and, more importantly, into the suboxic and anoxic layers over several small vertical scales ("fingers" of similar to5 m) at water densities (sigma(1)) from 15.0 to 16.4. O(2) injection oxidizes Mn(II) to Mn(III,IV), which then oxidizes H(2)S. The onset of H(2)S detection occurs in deeper waters in the southwest (>170 m; sigma(1) approximate to 16.4) relative to the west central Black Sea (110 m; sigma(1) approximate to 16.2) and coincides with increased MnO(2) and S(8) formation in the southwest

The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial.

Contains fulltext : 109856.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGROUND: In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30%. Studies have shown that minor intrauterine abnormalities can be found in 11-45% of infertile women with a normal transvaginal sonography or hysterosalpingography. Two randomised controlled trials have indicated that detection and treatment of these abnormalities by office hysteroscopy after two failed IVF cycles leads to a 9-13% increase in pregnancy rate. Therefore, screening of all infertile women for intracavitary pathology prior to the start of IVF/ICSI is increasingly advocated. In absence of a scientific basis for such a policy, this study will assess the effects and costs of screening for and treatment of unsuspected intrauterine abnormalities by routine office hysteroscopy, with or without saline infusion sonography (SIS), prior to a first IVF/ICSI cycle. METHODS/DESIGN: Multicenter randomised controlled trial in asymptomatic subfertile women, indicated for a first IVF/ICSI treatment cycle, with normal findings at transvaginal sonography. Women with recurrent miscarriages, prior hysteroscopy treatment and intermenstrual blood loss will not be included. Participants will be randomised for a routine fertility work-up with additional (SIS and) hysteroscopy with on-the-spot-treatment of predefined intrauterine abnormalities versus the regular fertility work-up without additional diagnostic tests. The primary study outcome is the cumulative ongoing pregnancy rate resulting in live birth achieved within 18 months of IVF/ICSI treatment after randomisation. Secondary study outcome parameters are the cumulative implantation rate; cumulative miscarriage rate; patient preference and patient tolerance of a SIS and hysteroscopy procedure. All data will be analysed according to the intention-to-treat principle, using univariate and multivariate logistic regression and cox regression. Cost-effectiveness analysis will be performed to evaluate the costs of the additional tests as routine procedure. In total 700 patients will be included in this study. DISCUSSION: The results of this study will help to clarify the significance of hysteroscopy prior to IVF treatment. TRIAL REGISTRATION: NCT01242852